Canada Global HARMONY: Prospective, Multi-site, Study to Evaluate Subject Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment
Phase of Trial: Phase IV
Latest Information Update: 05 Apr 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Deoxycholic acid (Primary)
- Indications Facial wrinkles; Glabellar lines
- Focus Therapeutic Use
- Acronyms HARMONY
- Sponsors Allergan
- 02 Apr 2019 Planned End Date changed from 30 Jun 2020 to 30 Aug 2020.
- 02 Apr 2019 Planned primary completion date changed from 30 Jun 2020 to 30 Aug 2020.
- 02 Apr 2019 Status changed from not yet recruiting to recruiting.